腫瘍性病変に対するサーマルアブレーションの現況
骨・軟部腫瘍のラジオ波焼灼治療
2023 年 38 巻 2 号 p. 83-88
詳細
2023 年 38 巻 2 号 p. 83-88
Japanese health insurance coverage for radiofrequency ablation (RFA) was extended to several diseases in September, 2022. The musculoskeletal tumors “malignant bone tumor”, “osteoid osteoma” and “soft tissue tumor (extremity, chest and abdomen) ” were adopted under the coverage. In this article, we discuss a precise RFA technique and protocol with a focus on patients with metastatic bone tumor and osteoid osteoma.
